New role for the IMA in 2021

7.1.2021

New roles

With the new Medicinal Products Act No. 100/2020 coming into force the IMA has taken on new roles which are as follows:

  • to determine maximum price for prescription medicinal products both at wholesale and retail level
  • to determine maximum price for all veterinary medicinal products both at wholesale and retail level (both prescription and over the counter medicinal products)
  • to determine if a medicinal product falls under reimbursement and determine the reimbursement price
  • to determine if a medicinal product is qualifies as a Specialty care high-cost medinal product
  • to determine if an unlicensed medicinal product which is listed in the Named Patient Program (NPP) falls under reimbursement.

Inquiries on the aforementioned roles should be sent to [email protected].

Information dissemination

All communication concerning the aforementioned roles will be performed by the IMA on or after 1st of January 2021.

Disclaimer and copyright

Back Send article